Köhler, Herdis

[["dc.bibliographiccitation.journal","Der Internist"],["dc.bibliographiccitation.volume","57"],["dc.contributor.author","Schroeter, M."],["dc.contributor.author","Koehler, H."],["dc.contributor.author","Wachter, Astrid"],["dc.contributor.author","Bleckmann, Annalen"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Schillinger, Wolfgang"],["dc.date.accessioned","2018-11-07T10:15:55Z"],["dc.date.available","2018-11-07T10:15:55Z"],["dc.date.issued","2016"],["dc.format.extent","S30"],["dc.identifier.isi","000375417500054"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/40917"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","New york"],["dc.relation.issn","1432-1289"],["dc.relation.issn","0020-9554"],["dc.title","The Early use of Impella-Ventricular Assist Devices in Patients with acute Coronary Syndrome and cardiogenic Shock is Based on the Advantage of 1-Year Mortality"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","467"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","The Journal of invasive cardiology"],["dc.bibliographiccitation.lastpage","472"],["dc.bibliographiccitation.volume","28"],["dc.contributor.author","Schroeter, Marco Robin"],["dc.contributor.author","Köhler, Herdis"],["dc.contributor.author","Wachter, Astrid"],["dc.contributor.author","Bleckmann, Annalen"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Schillinger, Wolfgang"],["dc.date.accessioned","2017-10-27T11:34:16Z"],["dc.date.available","2017-10-27T11:34:16Z"],["dc.date.issued","2016"],["dc.description.abstract","Impella is a microaxial rotary pump that is placed across the aortic valve to expel aspirated blood from the left ventricle into the ascending aorta; it can be used in cardiogenic shock. While previous studies have evaluated the efficacy and safety of the Impella device, more clinically relevant data are necessary, especially with regard to outcomes."],["dc.identifier.fs","623798"],["dc.identifier.pmid","27529657"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/9887"],["dc.language.iso","en"],["dc.notes.status","fcwi"],["dc.relation.eissn","1557-2501"],["dc.title","Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dspace.entity.type","Publication"]]